Pivmecillinam naming branding and safety are explained clearly
A familiar antibiotic has crossed an ocean with an unfamiliar name. In April 2024 the U.S. Food and Drug Administration approved Pivya pivmecillinam for uncomplicated urinary tract infection in adult women. That milestone reintroduced a workhorse long used across Europe where pivmecillinam has anchored first line care for cystitis for decades. Within months the U.S. […]